ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.8B | +15.5% | 5.3% | 14.8% |
| Free cash flow (TTM) | $7.8B |
|---|---|
| YoY | +15.5% |
| 5-year CAGR | 5.3% |
| 10-year CAGR | 14.8% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $7.4B | +16.4% |
| 2024 | $6.4B | +25.5% |
| 2023 | $5.1B | −35.2% |
| 2022 | $7.8B | −9.8% |
| 2021 | $8.6B | +51.1% |
| 2020 | $5.7B | +27.3% |
| 2019 | $4.5B | −8.3% |
| 2018 | $4.9B | +10.6% |
| 2017 | $4.4B | +113.0% |
| 2016 | $2.1B | +12.2% |
| 2015 | $1.9B | −28.6% |
| 2014 | $2.6B | +19.2% |
| 2013 | $2.2B | −71.0% |
| 2012 | $7.5B | +0.5% |
| 2011 | $7.5B | −3.1% |
| 2010 | $7.7B | +24.8% |
| 2009 | $6.2B | +8.4% |
| 2008 | $5.7B | +61.8% |
| 2007 | $3.5B | — |